04 August 2011

Maruti Suzuki- 1QFY2012 Result Update:: Angel Broking,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Maruti Suzuki (Maruti) reported an in-line operating performance for 1QFY2012;
however, net profit came in significantly higher than our estimates, driven by a
sharp jump in other income on account of long-term capital gains (~`40cr) and
high treasury yields on investments. We broadly maintain our volume and
earnings estimates and continue to maintain our Accumulate rating on the stock.
Muted top-line performance on flat volumes, other income boosts bottom line:
For 1QFY2012, Maruti reported 3.6% yoy (down 15.5% qoq) growth in net sales
to `8,529cr, in-line with our estimates, aided by a 4% yoy increase in average net
realisation, led by better product mix (higher contribution of diesel vehicles) and
price increases. Volume growth remained sluggish and posted a 0.6% yoy decline
(18% qoq), impacted largely by the demand slowdown in the small car segment
and production loss due to a 13-day strike at Manesar plant. EBITDA margin was
in-line with our estimates at 9.5% (almost flat yoy), but it was down by 46bp qoq.
Raw-material costs rose by 81bp yoy (70bp qoq) to 80.4% of sales, while royalty
and selling and distribution expenses declined by 50bp yoy each, thus benefitting
the margin. Net profit increased by 18% yoy (down 16.8% qoq) to `549cr, 22.6%
ahead of our estimates, led by higher-than-expected other income.
Outlook and valuation: We continue to remain positive on the long-term volume
growth in the passenger car industry, led by sustainable economic growth and
low penetration levels in the country. However, considering the near-term macro
headwinds, we remain cautious on short-term volume growth in the passenger
car industry. We expect Maruti to post a ~9% volume CAGR over FY2011–13E,
leading to a ~13% revenue CAGR. At `1,178, Maruti is trading at 13.1x and
11.6x its FY2012E and FY2013E earnings, respectively. We continue to maintain
our Accumulate recommendation on the stock with a target price of `1,322,
valuing it at 13x FY2013E earnings.

No comments:

Post a Comment